China · 
Who invested in Xunda Pharmaceutical?
Xunda Pharmaceutical's investors include Shenzhen Capital Group Co..
200920102011
$1.7MSeries A$653KSeries B
China · Series B startup
Who invested in Xunda Pharmaceutical
2 rounds we have observed, with the one investor named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Follow Xunda Pharmaceutical and see its new rounds in your feed. Start following
Funding summaryUpdated 15 Nov 2026
$2.4Mraised across 2 rounds since 2008, from 2 sources
$1.7MSeries A$653KSeries B
- Latest round
- Series B, $653KAug 2011
- Biggest round
- $1.7MSeries A · Jun 2008
- Investors
- 1
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Series A, $1.7M Jun 2008
- Biggest round
- $1.7M Series A · Jun 2008
- Between rounds
- 3.2 years from the last two
The rounds
- Aug 2011Series B$653K
No investor was named in the report.
From a historical funding record
- Jun 2008
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Xunda Pharmaceutical
How much has Xunda Pharmaceutical raised?
Xunda Pharmaceutical has raised $2.4M across 2 rounds since 2008.
When did Xunda Pharmaceutical last raise?
Xunda Pharmaceutical's most recent round was a Series B of $653K in Aug 2011.
What was Xunda Pharmaceutical's biggest round?
Xunda Pharmaceutical's largest round on record is $1.7M (Series A), in Jun 2008.
Who backed Xunda Pharmaceutical first?
Xunda Pharmaceutical's first round on record, in Jun 2008, was backed by Shenzhen Capital Group Co..
What stage is Xunda Pharmaceutical at?
Xunda Pharmaceutical's latest named round is a Series B, in Aug 2011.
Where is Xunda Pharmaceutical based?
Xunda Pharmaceutical is based in China.
Companies like Xunda Pharmaceutical
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.